It is the responsibility of The University of Texas at Austin (University) Institutional Biosafety Committee (IBC) to review, approve and oversee the use of recombinant or synthetic nucleic acid molecules (rsNA) research, biohazardous agents, materials and toxins in all research or teaching activities conducted at or sponsored by the University.
The mission of the Institutional Biosafety Committee is to ensure the University safeguards human health and the environment by maintaining an adherence with:
- NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) (PDF)
- Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th edition
- USDA Animal and Plant Inspection Service Biotechnology Regulatory services (APHIS/BRS)
- HHS and USDA Rules for the Possession, Use, and Transfer of Select Agents and Toxins 42 C.F.R. Part 73, 7 C.F.R. Part 331, and 9 C.F.R. Part 121
- United States Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern (PDF)
- U.S. Food and Drug Administration (FDA)
The University IBC reviews research and teaching activities using the following materials:
- Recombinant or synthetic nucleic acid molecules
- Human or nonhuman primate body fluids, cells or tissue
- Infectious agents or biotoxins
- Select Agents and Toxins or Dual Use Research of Concern (DURC)
Through a balance of outreach and support for research personnel, the IBC will:
- Assure activities meet the ethical and legal requirements for the responsible use of rsNA, biohazardous agents, materials and toxins.
- Establish policies and make recommendations to the University regarding such activities.
- Minimize risks to the research personnel, community and the environment by educating the University community regarding the regulatory requirements for the use of rsNA, biohazardous agents, materials and toxins.